Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

被引:1155
作者
Bergstrand, Martin [1 ]
Hooker, Andrew C. [1 ]
Wallin, Johan E. [1 ,2 ]
Karlsson, Mats O. [1 ]
机构
[1] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden
[2] Lilly PKPD&TS, Windlesham, Surrey, England
来源
AAPS JOURNAL | 2011年 / 13卷 / 02期
关键词
mixed-effects modeling; model diagnostics; pcVPC; prediction correction; VPC; NONMEM; PSN;
D O I
10.1208/s12248-011-9255-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Informative diagnostic tools are vital to the development of useful mixed-effects models. The Visual Predictive Check (VPC) is a popular tool for evaluating the performance of population PK and PKPD models. Ideally, a VPC will diagnose both the fixed and random effects in a mixed-effects model. In many cases, this can be done by comparing different percentiles of the observed data to percentiles of simulated data, generally grouped together within bins of an independent variable. However, the diagnostic value of a VPC can be hampered by binning across a large variability in dose and/or influential covariates. VPCs can also be misleading if applied to data following adaptive designs such as dose adjustments. The prediction-corrected VPC (pcVPC) offers a solution to these problems while retaining the visual interpretation of the traditional VPC. In a pcVPC, the variability coming from binning across independent variables is removed by normalizing the observed and simulated dependent variable based on the typical population prediction for the median independent variable in the bin. The principal benefit with the pcVPC has been explored by application to both simulated and real examples of PK and PKPD models. The investigated examples demonstrate that pcVPCs have an enhanced ability to diagnose model misspecification especially with respect to random effects models in a range of situations. The pcVPC was in contrast to traditional VPCs shown to be readily applicable to data from studies with a priori and/or a posteriori dose adaptations.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 27 条
  • [1] [Anonymous], 2009, R LANG ENV STAT COMP
  • [2] Beal SS, 1989, NONMEM User's Guides
  • [3] BERGSTRAND M, 2009, PREDICTION CORRECTED
  • [4] Handling Data Below the Limit of Quantification in Mixed Effect Models
    Bergstrand, Martin
    Karlsson, Mats O.
    [J]. AAPS JOURNAL, 2009, 11 (02): : 371 - 380
  • [5] Box GEP, 1987, Empirical model-building and response surfaces
  • [6] Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure
    Brynne, L
    McNay, JL
    Schaefer, HG
    Swedberg, K
    Wiltse, CG
    Karlsson, MO
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (01) : 35 - 43
  • [7] Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models:: The npde add-on package for R
    Comets, Emmanuelle
    Brendel, Karl
    Mentre, France
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2008, 90 (02) : 154 - 166
  • [8] Comets E, 2010, J SFDS, V151, P106
  • [9] Approaches to handling pharmacodynamic baseline responses
    Dansirikul, Chantaratsamon
    Silber, Hanna E.
    Karlsson, Mats O.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2008, 35 (03) : 269 - 283
  • [10] Modeling and Simulation of the Time Course of Asenapine Exposure Response and Dropout Patterns in Acute Schizophrenia
    Friberg, L. E.
    de Greef, R.
    Kerbusch, T.
    Karlsson, M. O.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) : 84 - 91